Sex differences in a mouse model of synucleinopathy reveals female resilience to disease progression despite early brain pathology, contrasting with accelerated disease in male mice after alpha ...

Scientists have identified new elements that may play a crucial role in how Parkinson’s disease spreads through the brain Scientists discovered that too much of the cholesterol by-product can harm ...

A by-product of cholesterol plays a "pivotal" role in Parkinson’s disease, according to new research. The metabolite is critical in the development of the neurodegenerative condition in mice ...

At just 45, Jules King says the painful, stiff muscles she experienced with her Parkinson's disease made her feel as if she were 'trapped in an 85-year-old's body'. But she has now found some ...

The face can change with Parkinson's disease, and facial masking (also called masked facies, or hypomimia) occurs in roughly half to 70% of all people diagnosed with the neurodegenerative condition.

Ozzy Osbourne is “very happy” about his forthcoming final concert even if his battle with Parkinson’s disease continues to take a physical toll, according to his wife. Sharon Osbourne ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

Around 1 million people have Parkinson's disease in the United States, according to government data. In a late-stage study, the combination reduced the daily periods of "off episodes" by more than ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine ...